Sanovas is disrupting and expanding multi-billion dollar diagnostic and therapeutic categories by improving quality and cost-effective access to advanced minimally invasive technologies worldwide. We are providing safe, easy, affordable access and visualization in small anatomies to enable advanced diagnostic and therapeutic interventions. Below is an overview video of the Sanovas investment opportunity presented by Larry Gerrans, CEO.
If you would like to receive more detailed information regarding Sanovas investment opportunities, please click on the link below. You will be directed to complete information that complies with the Securities and Exchange Commission's (SEC) rule 506(d) requirements. You will also be asked to complete a non-disclosure agreement (NDA).Read and Sign the Sanovas NDA for Investors